Moderna
MRNA
#1684
Rank
NZ$16.06 B
Marketcap
$41.54
Share price
0.83%
Change (1 day)
-76.58%
Change (1 year)
Moderna, Inc. is an American biotechnology company focused on the discovery and development of messenger RNA-based drugs.

Moderna (MRNA) Fails to deliver data

Key failure to deliver metrics for Moderna :

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for Moderna (MRNA) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for Moderna (MRNA) - since 2018

Volume in USD (price x number of shares), data since 2018

Moderna (MRNA) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2025NZ$23.2 M-85.15%
2024NZ$0.15 B15.08%
2023NZ$0.13 B-50.15%
2022NZ$0.27 B-85.7%
2021NZ$1.90 B158.2%
2020NZ$0.73 B369.18%
2019NZ$0.15 B1011.49%
2018NZ$14.15 M

FTD volume in the last 3 months for similar companies or competitors

Company FTD volume (3 months) FTD volume (1 year) Country
NZ$1.09 MNZ$5.43 M๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$57.2 MNZ$0.17 B๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$0.09 MNZ$0.71 M๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$9.85 MNZ$37.8 M๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$44.97 MNZ$0.15 B๐Ÿ‡จ๐Ÿ‡ญ Switzerland
NZ$3.01 MNZ$8.57 M๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$17.09 MNZ$0.20 B๐Ÿ‡บ๐Ÿ‡ธ USA